The U.N. Commission on Narcotic Drugs voted Wednesday to remove cannabis and cannabis resin from a category of the world's most dangerous drugs, according to CBS News.
Experts reportedly say the decision has the potential to impact the global medical marijuana industry.
The Vienna-based U.N. agency said in a statement that it had voted 27-25, with one abstention, to follow the World Health Organization (WHO)'s recommendation to remove cannabis and cannabis resin from Schedule IV of the 1961 Convention on Narcotic Drugs, where it was listed with heroin and several other opioids.
The drugs that are on Schedule IV are a subset of those on Schedule I of the convention, which already requires the highest levels of international control. The agency voted to leave cannabis and cannabis resin on the list of Schedule I drugs, which also includes cocaine, Fentanyl, morphine, Methadone, opium and oxycodone, the opiate painkiller sold as OxyContin.
Cannabis, also known as marijuana, is a psychoactive drug from the Cannabis plant used primarily for medical or recreational purposes. The main psychoactive component of cannabis is tetrahydrocannabinol (THC), which is one of the 483 known compounds in the plant, including at least 65 other cannabinoids, including cannabidiol (CBD). Cannabis can be used by smoking, vaporizing, within food, or as an extract.
Tajik FM, CSTO SG discuss implementation of decisions taken by CSTO Security Council last month
Government endorses a list of SOEs going under control of supervisory boards
Coronavirus case numbers have not changed in Tajikistan this month so far
Central Asia Rule of Law Program 2020-2023 to be officially launched in late January
ADB supports improvement of Tajikistan’s power sector, road network safety and fiscal management
Training center for Central Asian and Afghan rescuers to be built in Tajikistan
Dushanbe-2 CHP plant directs generated electricity to the country’s power grid
First consignment of doses of Sputnik V vaccine arrives in Tajikistan for Russian servicemen
Labor migration from Central Asian countries to Europe gradually gaining momentum in numerical ratio
Uzbekistan to buy 100,000 doses of Pfizer, BioNTech vaccine
All news
Авторизуйтесь, пожалуйста